Nadeeka Shiyamalee Udawatte

Nadeeka Shiyamalee Udawatte

Auto-generated profile, based on publicly available information

Nadeeka Shiyamalee Udawatte

Singapore Oral Microbiomics Initiative, National Dental Research Institute Singapore (NDRIS), National Dental Centre Singapore, Oral Health ACP, Duke NUS Medical School, Singapore

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 April 2022 in Journal of Oral Microbiology
Verified
Journal Article
Open access
AWArmelia Sari Widyarman
Armelia Sari Widyarman
NUNadeeka S. Udawatte
Nadeeka S. Udawatte
MRMoehamad Orliando Roeslan
Moehamad Orliando Roeslan
MRMuhammad Ihsan Rizal
Muhammad Ihsan Rizal
MRMario Richi
Mario Richi
CSChaminda Jayampath Seneviratne
Chaminda Jayampath Seneviratne
This prospective clinical study aim was to analyze the effect of the probiotic Lactobacillus reuteri Prodentis lozenges on salivary microbiome of subjects wearing fixed orthodontic appliances.Saliv...

6 October 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
NUNadeeka Shiyamalee Udawatte
Nadeeka Shiyamalee Udawatte
KWKang Sung Wook
Kang Sung Wook
YWYue Wang
Yue Wang
SMSilvia Manzanero
Silvia Manzanero
TAThiruma Valvan Arumugam
Thiruma Valvan Arumugam
CSChaminda Jayampath Seneviratne
Chaminda Jayampath Seneviratne
The effects of antifungal agents on the human microbiome can be challenging to study due to confounding factors such as the underlying disease states and concomitant use of antibiotics and other therapies. We elucidated longitudinal modification of gut microbiome in response to a short course (5 days) of antifungal treatment in healthy male Sprague-Dawley (SD) rats by sequencing 16S rRNA V1–V3 and ITS2 hypervariable regions. SD rats were randomized into a control group and three antifungal treated (AT) groups including Amphotericin B (AmB), voriconazole and, our novel antifungal drug candidate SM21 once per day for 5 consecutive days. Fecal samples were collected at three different time points (day 0, day 1 and day 5). Microbial communities of both bacteria and fungi were compared between conditions. In silico analysis of differential microbial abundance and the predictive functional domains of microbial communities was further done by inferring metabarcoding profiles from 16S data. AT animals exhibited significant change in bacteriome alphadiversity although no divergence in community structure (beta-diversity) was observed compared with respective control groups (day 0). Specific bacterial clades and taxa were longitudinally and significantly modified in the AT animals. The AT bacterium of AmB and SM21 was particularly enriched in probiotic Lactobacillus strains including L. reuteri . The key pathways overrepresented in the bacteriome under AT animals were linked to cellular processes, environment information processing and metabolism. Moreover, AT treated mycobiome diversity decreased longitudinally with insignificant variations along the time course; different fungal taxa dominating at different timepoints in a wave-like fashion. However, acute antifungal treatments could not alter healthy gut microbial community structure. Hence, the healthy gut microbiome is capable of resisting a major dysbiotic shift during a short course of antifungal treatment.